|
Daily Medical Update
Obstructive sleep apnea
Wednesday, June 10, 2026
|
🔬 Practice-Changing Findings
Evidence from RCTs and meta-analyses published in the
last 12 months.
|
Medicina (Kaunas, Lithuania) (2025) - Systematic Review and Meta-Analysis
Key Findings
- OSA was associated with increased cardiovascular risk overall (HR 1.82, 95% CI 1.45-2.28), with risk rising from mild disease (HR 1.21) to severe disease (HR 2.45).
- CPAP adherence of at least 4 hours/night reduced cardiovascular risk (HR 0.76, 95% CI 0.60-0.96).
📋 Practice Implication: Use OSA severity and nightly CPAP adherence as cardiovascular risk modifiers when counseling patients and prioritizing follow-up.
|
Sleep & breathing = Schlaf & Atmung (2025) - Systematic Review and Meta-Analysis
Key Findings
- Pulmonary hypertension was present in 29.3% of patients with OSA defined by AHI >= 5, and prevalence increased to 35.5% in studies using AHI >= 10.
- OSA patients with pulmonary hypertension had higher BMI (MD 3.432), AHI (MD 12.6), ODI (SMD 0.497), and time with SpO2 < 90% (SMD 0.641), with lower mean SpO2 (SMD -0.885).
📋 Practice Implication: Consider earlier cardiopulmonary evaluation in OSA patients with obesity, heavier nocturnal desaturation, or higher event burden.
|
Sleep medicine (2026) - Network Meta-Analysis
Key Findings
- CPAP was the most effective therapy for reducing AHI and improving minimum SpO2 across 55 randomized trials.
- Oropharyngeal myofunctional therapy reduced daytime sleepiness more than CPAP, and CPAP plus inspiratory muscle training improved sleep quality more than CPAP alone.
📋 Practice Implication: Keep CPAP as first-line respiratory therapy, but match adjuncts or alternatives to the symptom target when adherence or residual complaints limit benefit.
|
Sleep medicine (2026) - Systematic Review and Meta-Analysis
Key Findings
- Non-surgical weight loss interventions reduced AHI by 11.10 events/hour and lowered body weight by 6.53 kg and BMI by 2.40 kg/m2.
- These interventions also improved systolic blood pressure by 6.51 mmHg and diastolic blood pressure by 3.26 mmHg, with benefits most robust in the short to mid-term.
📋 Practice Implication: Build structured weight-loss treatment into initial OSA care for patients with obesity instead of treating airway disease in isolation.
|
Journal of hypertension (2025) - Systematic Review and Meta-Analysis
Key Findings
- CPAP improved left ventricular global longitudinal strain by 1.92% and right ventricular global longitudinal strain by 1.88% in patients with OSA.
- CPAP also reduced pulmonary artery systolic pressure by 5.23 mmHg and right atrial volume index by 3.96 mL/m2, without significant changes in LVEF or TAPSE.
📋 Practice Implication: Use cardiac remodeling data to reinforce CPAP treatment value in OSA patients with suspected right-sided strain or subclinical ventricular dysfunction.
|
|
💡
Summary
Recent higher-significance evidence in obstructive sleep apnea centers on risk stratification and multi-domain treatment benefit: untreated OSA tracks with higher cardiovascular risk and a substantial pulmonary hypertension burden, while effective therapy improves respiratory, cardiometabolic, and cardiac remodeling outcomes. CPAP remains the most effective option for respiratory control, but newer comparative and weight-loss syntheses support tailored adjuncts or alternatives for patients with adherence problems, obesity, or persistent symptoms.
|
|